Advertisement
Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     



Correspondence: When an article is eligible for submission of Correspondence, a link to the response form is available within the full-text article. You must be a current subscriber who has activated the online portion of your subscription in order to send a Correspondence. Any reader can read published Correspondence.

Correspondence to:

ARTICLES:
P.T. Donnan, D.T. Steinke, C. Stubbings, P.G. Davey, and T.M. MacDonald
Selegiline and mortality in subjects with Parkinson’s disease: A longitudinal community study
Neurology 2000; 55: 1785-1789 [Abstract] [Full text] [PDF]
*Correspondence:
  Submit a response to this article

Correspondence published:

[Read Correspondence] Selegiline and mortality in subjects with PD
Y Ben-Shlomo, "J Head, A Lees"   (28 April 2001)
[Read Correspondence] Reply to Van Gerpen and Ahlskog
Peter T Donnan, "Doug T Steinke, Peter G Davey, Thomas M MacDonald"   (28 April 2001)
[Read Correspondence] Selegiline and mortality in subjects with PD
J A Van Gerpen, J E Ahlskog   (28 April 2001)

Selegiline and mortality in subjects with PD 28 April 2001
  Top
Y Ben-Shlomo
UK-PDRG/University of Bristol,
"J Head, A Lees"

Send Correspondence to journal:
Re: Selegiline and mortality in subjects with PD

y.ben-shlomo{at}bris.ac.uk Y Ben-Shlomo, et al.

Reply to Van Gerpen and Ahlskog 28 April 2001
  Top
Peter T Donnan
University of Dundee, UK,
"Doug T Steinke, Peter G Davey, Thomas M MacDonald"

Send Correspondence to journal:
Re: Reply to Van Gerpen and Ahlskog

peterd{at}memo.dundee.ac.uk Peter T Donnan, et al.

Selegiline and mortality in subjects with PD 28 April 2001
  Top
J A Van Gerpen
Mayo Clinic,
J E Ahlskog

Send Correspondence to journal:
Re: Selegiline and mortality in subjects with PD

vangerpen.jay{at}mayo.edu J A Van Gerpen, et al.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by AAN Enterprises, Inc.
Advertisement